Literature DB >> 26063668

Change in Intra-Abdominal Fat Predicts the Risk of Hypertension in Japanese Americans.

Catherine A Sullivan1, Steven E Kahn1, Wilfred Y Fujimoto1, Tomoshige Hayashi1, Donna L Leonetti1, Edward J Boyko2.   

Abstract

In Japanese Americans, intra-abdominal fat area measured by computed tomography is positively associated with the prevalence and incidence of hypertension. Evidence in other populations suggests that other fat areas may be protective. We sought to determine whether a change in specific fat depots predicts the development of hypertension. We prospectively followed up 286 subjects (mean age, 49.5 years; 50.4% men) from the Japanese American Community Diabetes Study for 10 years. At baseline, subjects did not have hypertension (defined as blood pressure ≥140/90 mm Hg) and were not taking blood pressure or glucose-lowering medications. Mid-thigh subcutaneous fat area, abdominal subcutaneous fat area, and intra-abdominal fat area were directly measured by computed tomography at baseline and 5 years. Logistic regression was used to estimate odds of incident hypertension over 10 years in relation to a 5-year change in fat area. The relative odds of developing hypertension for a 5-year increase in intra-abdominal fat was 1.74 (95% confidence interval, 1.28-2.37), after adjusting for age, sex, body mass index, baseline intra-abdominal fat, alcohol use, smoking status, and weekly exercise energy expenditure. This relationship remained significant when adjusted for baseline fasting insulin and 2-hour glucose levels or for diabetes mellitus and pre-diabetes mellitus classification. There were no significant associations between baseline and change in thigh or abdominal subcutaneous fat areas and incident hypertension. In conclusion, in this cohort of Japanese Americans, the risk of developing hypertension is related to the accumulation of intra-abdominal fat rather than the accrual of subcutaneous fat in either the thigh or the abdominal areas.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  Asian Americans; adiposity; hypertension; intra-abdominal fat

Mesh:

Substances:

Year:  2015        PMID: 26063668      PMCID: PMC4467450          DOI: 10.1161/HYPERTENSIONAHA.114.04990

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  36 in total

1.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

2.  The association of regional fat depots with hypertension in older persons of white and African American ethnicity.

Authors:  Jingzhong Ding; Marjolein Visser; Stephen B Kritchevsky; Michael Nevitt; Anne Newman; Kim Sutton-Tyrrell; Tamara B Harris
Journal:  Am J Hypertens       Date:  2004-10       Impact factor: 2.689

3.  Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans.

Authors:  Tomoshige Hayashi; Edward J Boyko; Donna L Leonetti; Marguerite J McNeely; Laura Newell-Morris; Steven E Kahn; Wilfred Y Fujimoto
Journal:  Ann Intern Med       Date:  2004-06-15       Impact factor: 25.391

4.  Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study.

Authors:  M B Snijder; P Z Zimmet; M Visser; J M Dekker; J C Seidell; J E Shaw
Journal:  Int J Obes Relat Metab Disord       Date:  2004-03

5.  Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men.

Authors:  W Y Fujimoto; D L Leonetti; J L Kinyoun; L Newell-Morris; W P Shuman; W C Stolov; P W Wahl
Journal:  Diabetes       Date:  1987-06       Impact factor: 9.461

6.  Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance.

Authors:  W Y Fujimoto; D L Leonetti; J L Kinyoun; W P Shuman; W C Stolov; P W Wahl
Journal:  Diabetes       Date:  1987-06       Impact factor: 9.461

7.  Physical activity as an index of heart attack risk in college alumni.

Authors:  R S Paffenbarger; A L Wing; R T Hyde
Journal:  Am J Epidemiol       Date:  1978-09       Impact factor: 4.897

8.  Relation of body fat distribution to metabolic complications of obesity.

Authors:  A H Kissebah; N Vydelingum; R Murray; D J Evans; A J Hartz; R K Kalkhoff; P W Adams
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

9.  Abnormal body fat distribution detected by computed tomography in diabetic men.

Authors:  W P Shuman; L L Morris; D L Leonetti; P W Wahl; V M Moceri; A A Moss; W Y Fujimoto
Journal:  Invest Radiol       Date:  1986-06       Impact factor: 6.016

Review 10.  Lipid overload and overflow: metabolic trauma and the metabolic syndrome.

Authors:  Roger H Unger
Journal:  Trends Endocrinol Metab       Date:  2003-11       Impact factor: 12.015

View more
  18 in total

1.  Experimental Weight Gain Increases Ambulatory Blood Pressure in Healthy Subjects: Implications of Visceral Fat Accumulation.

Authors:  Naima Covassin; Fatima H Sert-Kuniyoshi; Prachi Singh; Abel Romero-Corral; Diane E Davison; Francisco Lopez-Jimenez; Michael D Jensen; Virend K Somers
Journal:  Mayo Clin Proc       Date:  2018-05       Impact factor: 7.616

2.  Baseline estradiol concentration in community-dwelling Japanese American men is not associated with intra-abdominal fat accumulation over 10 years.

Authors:  Beverly M Kocarnik; Edward J Boyko; Alvin M Matsumoto; Wilfred Y Fujimoto; Tomoshige Hayashi; Donna L Leonetti; Stephanie T Page
Journal:  Obes Res Clin Pract       Date:  2015-12-31       Impact factor: 2.288

3.  Association of Changes in Abdominal Fat Quantity and Quality With Incident Cardiovascular Disease Risk Factors.

Authors:  Jane J Lee; Alison Pedley; Udo Hoffmann; Joseph M Massaro; Caroline S Fox
Journal:  J Am Coll Cardiol       Date:  2016-10-04       Impact factor: 24.094

4.  Ideal cardiovascular health and incident hypertension: The longitudinal community-based Kailuan study.

Authors:  Hai Yan Zhao; Xiao Xue Liu; An Xin Wang; Yun Tao Wu; Xiao Ming Zheng; Xiao Hong Zhao; Kai Cui; Chun Yu Ruan; Cheng Zhi Lu; Jost B Jonas; Shou Ling Wu
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

5.  Apolipoprotein B Levels Predict Future Development of Hypertension Independent of Visceral Adiposity and Insulin Sensitivity.

Authors:  Seung Jin Han; Wilfred Y Fujimoto; Steven E Kahn; Donna L Leonetti; Edward J Boyko
Journal:  Endocrinol Metab (Seoul)       Date:  2020-06-24

6.  An association between subcutaneous fat mass accumulation and hypertension.

Authors:  Kento Goto; Hirohide Yokokawa; Hiroshi Fukuda; Mizue Saita; Chieko Hamada; Teruhiko Hisaoka; Toshio Naito
Journal:  J Gen Fam Med       Date:  2021-03-04

7.  Association of Body Fat Mass and Fat Distribution With the Incidence of Hypertension in a Population-Based Chinese Cohort: A 22-Year Follow-Up.

Authors:  Yongjie Chen; Xuan Liang; Senshuang Zheng; Yuan Wang; Wenli Lu
Journal:  J Am Heart Assoc       Date:  2018-03-16       Impact factor: 5.501

8.  Relationship between the exposure to cumulative cardiovascular health behaviors and factors and chronic kidney disease-The Kailuan study.

Authors:  Jinhong Hou; Junjuan Li; Jinjie Huang; Chunhong Lu; Jing Zhou; Yang Liu; Shouling Wu; Fang Wei; Lihua Wang; Haiyan Chen; Haibo Yu; Zhe Wang; Aili Jiang
Journal:  PLoS One       Date:  2018-08-31       Impact factor: 3.240

9.  Indicators of accumulated fat are stronger associated with prehypertension compared with indicators of circulating fat: A cross-sectional study.

Authors:  Susana Rivera-Mancía; Eloisa Colín-Ramírez; Raúl Cartas-Rosado; Oscar Infante; Jesús Vargas-Barrón; Maite Vallejo
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

10.  Higher High Density Lipoprotein 2 (HDL2) to Total HDL Cholesterol Ratio Is Associated with a Lower Risk for Incident Hypertension.

Authors:  You Cheol Hwang; Wilfred Y Fujimoto; Steven E Kahn; Donna L Leonetti; Edward J Boyko
Journal:  Diabetes Metab J       Date:  2018-09-28       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.